according to some chinese source, they are selling EV71 for RMB150 a dose. given the manufacture capacity is 20mil does/per year. that will give the revenue number of RMB3Billion ($480mil) per year. Let's be conservative and count only 60% of this revenue, that will be $280mil per year. Let's be conservative again and give a profit rate of just 20% (should be much higher 20%). the profit from EV71 alone will be at least $56mil per year. If you give it a PE of 10, a share worth at least $10, just based on the EV71 alone.
And we all know there are a lot other potentials in SVA's pipeline. $6.18 a share is a joke. I am wondering what we can do to make this deal fail.